Regeneron Pharmaceuticals (NQ: REGN )
1,192.23
-4.65
(-0.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Headline News about Regeneron Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
14 Analysts Assess Regeneron Pharmaceuticals: What You Need To Know
December 18, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Price Over Earnings Overview: Regeneron Pharmaceuticals
December 18, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/758282/gettyimages-new-year-2024-fireworks.jpg)
![](https://investorplace.com/wp-content/uploads/2023/02/ai-artificial-intelligence-pen-chart-1600.jpg)
![](https://g.foolcdn.com/editorial/images/757806/a-couple-smiling-and-talking-with-an-advisor.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
December 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
11 Analysts Have This to Say About Regeneron Pharmaceuticals
November 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
How Is The Market Feeling About Regeneron Pharmaceuticals?
November 16, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://g.foolcdn.com/editorial/images/756929/rich-couple-on-a-boat.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://g.foolcdn.com/editorial/images/756902/growth-trend.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Where Regeneron Pharmaceuticals Stands With Analysts
November 09, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/754012/person-sitting-and-working-at-a-desk.jpg)
2 Soaring Stocks to Buy and Hold
November 09, 2023
Via The Motley Fool
![](https://investorplace.com/wp-content/uploads/2019/07/goog1600i.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://www.investors.com/wp-content/uploads/2020/08/Stock-regeneron-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/27/regn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://www.investors.com/wp-content/uploads/2022/07/Stock-celldex-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/06/advm.png?width=1200&height=800&fit=crop)
Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today?
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/03/regn.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/04/Stock-bullfightingbear-01-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.